Related Experiment Video
Updated: Aug 3, 2025

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
12.7K
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
N Zioni1, A Akhiad Bercovich2, N Chapal-Ilani1
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Nature Communications
|April 12, 2023
Summary
Fatty bone marrow (FBM) promotes the growth of aging hematopoietic stem cells (HSCs) with mutations. This inflammatory process, driven by IL-6, can be blocked, offering a potential therapeutic target for clonal hematopoiesis.
Area of Science:
- Hematology
- Aging Research
- Stem Cell Biology
Background:
- Fatty bone marrow (FBM) and somatic mutations in hematopoietic stem cells (HSCs), known as clonal hematopoiesis (CH), increase with age.
- The interaction between FBM and CH evolution is not well understood.
Purpose of the Study:
- To investigate the influence of FBM on the development of CH.
- To explore the mechanisms underlying this interaction.
Main Methods:
- Utilized two preclinical male mouse models (sub-lethal irradiation and castration).
- Employed an adipogenesis inhibitor (PPARγ inhibitor) as a control.
- Performed single-cell RNA-sequencing on rodent HSCs.
- Conducted cytokine analysis of bone marrow (BM) fluid and BM-derived adipocytes.
- Used anti-IL-6 neutralizing antibodies.
Main Results:
- FBM significantly increased self-renewal of DNMT3A-mutated HSCs (DNMT3AMut-HSCs) in both human and rodent models.
- Older mice with FBM showed even higher self-renewal in their DNMT3AMut-HSCs.
- FBM exposure led to a 6-10 fold increase in DNMT3AMut-HSCs and activated inflammatory signaling.
- Increased IL-6 levels were observed in FBM conditions.
- Blocking IL-6 significantly reduced the selective advantage of DNMT3AMut-HSCs.
Conclusions:
- Paracrine inflammatory signals from FBM promote DNMT3A-driven clonal hematopoiesis.
- The IL-6 pathway plays a critical role in mediating this effect.
- Inhibiting the IL-6 pathway offers a potential strategy to counteract FBM-induced CH.
Related Concept Videos
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

